Global Cancer Ablation Devices Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18699639 | Publishing Date : 06-Jul-2021 | No. of pages : 135
Detailed TOC of Global Cancer Ablation Devices Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Cancer Ablation Devices Market Overview1.1 Cancer Ablation Devices Product Overview
1.2 Cancer Ablation Devices Market Segment by Type
1.2.1 Cryoablation
1.2.2 High-Intensity Focused Ultrasound (HIFU)
1.2.3 Laser Interstitial Thermal Therapy (LiTT)
1.2.4 Microwave Ablation (MWA)
1.2.5 Radiofrequency Ablation (RFA)
1.2.6 Irreversible Electroporation (Ire)
1.2.7 Non-Thermal Ablation
1.3 Global Cancer Ablation Devices Market Size by Type
1.3.1 Global Cancer Ablation Devices Market Size Overview by Type (2016-2027)
1.3.2 Global Cancer Ablation Devices Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Cancer Ablation Devices Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Cancer Ablation Devices Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Cancer Ablation Devices Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Cancer Ablation Devices Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Cancer Ablation Devices Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Cancer Ablation Devices Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Cancer Ablation Devices Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cancer Ablation Devices Sales Breakdown by Type (2016-2021)
1.4.2 Europe Cancer Ablation Devices Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Cancer Ablation Devices Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Cancer Ablation Devices Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Cancer Ablation Devices Sales Breakdown by Type (2016-2021)
2 Global Cancer Ablation Devices Market Competition by Company
2.1 Global Top Players by Cancer Ablation Devices Sales (2016-2021)
2.2 Global Top Players by Cancer Ablation Devices Revenue (2016-2021)
2.3 Global Top Players Cancer Ablation Devices Price (2016-2021)
2.4 Global Top Manufacturers Cancer Ablation Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cancer Ablation Devices Market Competitive Situation and Trends
2.5.1 Cancer Ablation Devices Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Cancer Ablation Devices Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Ablation Devices as of 2020)
2.7 Date of Key Manufacturers Enter into Cancer Ablation Devices Market
2.8 Key Manufacturers Cancer Ablation Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cancer Ablation Devices Status and Outlook by Region
3.1 Global Cancer Ablation Devices Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Cancer Ablation Devices Historic Market Size by Region
3.2.1 Global Cancer Ablation Devices Sales in Volume by Region (2016-2021)
3.2.2 Global Cancer Ablation Devices Sales in Value by Region (2016-2021)
3.2.3 Global Cancer Ablation Devices Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Cancer Ablation Devices Forecasted Market Size by Region
3.3.1 Global Cancer Ablation Devices Sales in Volume by Region (2022-2027)
3.3.2 Global Cancer Ablation Devices Sales in Value by Region (2022-2027)
3.3.3 Global Cancer Ablation Devices Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Cancer Ablation Devices by Application
4.1 Cancer Ablation Devices Market Segment by Application
4.1.1 Brain Cancer
4.1.2 Brown
4.1.3 Colorectal Cancer
4.1.4 Kidney Cancer
4.1.5 Liver Cancer
4.1.6 Lung Cancer
4.1.7 Pancreatic Cancer
4.1.8 Prostate Cancer
4.2 Global Cancer Ablation Devices Market Size by Application
4.2.1 Global Cancer Ablation Devices Market Size Overview by Application (2016-2027)
4.2.2 Global Cancer Ablation Devices Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Cancer Ablation Devices Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Cancer Ablation Devices Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Cancer Ablation Devices Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Cancer Ablation Devices Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Cancer Ablation Devices Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Cancer Ablation Devices Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Cancer Ablation Devices Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cancer Ablation Devices Sales Breakdown by Application (2016-2021)
4.3.2 Europe Cancer Ablation Devices Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Cancer Ablation Devices Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Cancer Ablation Devices Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Cancer Ablation Devices Sales Breakdown by Application (2016-2021)
5 North America Cancer Ablation Devices by Country
5.1 North America Cancer Ablation Devices Historic Market Size by Country
5.1.1 North America Cancer Ablation Devices Sales in Volume by Country (2016-2021)
5.1.2 North America Cancer Ablation Devices Sales in Value by Country (2016-2021)
5.2 North America Cancer Ablation Devices Forecasted Market Size by Country
5.2.1 North America Cancer Ablation Devices Sales in Volume by Country (2022-2027)
5.2.2 North America Cancer Ablation Devices Sales in Value by Country (2022-2027)
6 Europe Cancer Ablation Devices by Country
6.1 Europe Cancer Ablation Devices Historic Market Size by Country
6.1.1 Europe Cancer Ablation Devices Sales in Volume by Country (2016-2021)
6.1.2 Europe Cancer Ablation Devices Sales in Value by Country (2016-2021)
6.2 Europe Cancer Ablation Devices Forecasted Market Size by Country
6.2.1 Europe Cancer Ablation Devices Sales in Volume by Country (2022-2027)
6.2.2 Europe Cancer Ablation Devices Sales in Value by Country (2022-2027)
7 Asia-Pacific Cancer Ablation Devices by Region
7.1 Asia-Pacific Cancer Ablation Devices Historic Market Size by Region
7.1.1 Asia-Pacific Cancer Ablation Devices Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Cancer Ablation Devices Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Cancer Ablation Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Cancer Ablation Devices Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Cancer Ablation Devices Sales in Value by Region (2022-2027)
8 Latin America Cancer Ablation Devices by Country
8.1 Latin America Cancer Ablation Devices Historic Market Size by Country
8.1.1 Latin America Cancer Ablation Devices Sales in Volume by Country (2016-2021)
8.1.2 Latin America Cancer Ablation Devices Sales in Value by Country (2016-2021)
8.2 Latin America Cancer Ablation Devices Forecasted Market Size by Country
8.2.1 Latin America Cancer Ablation Devices Sales in Volume by Country (2022-2027)
8.2.2 Latin America Cancer Ablation Devices Sales in Value by Country (2022-2027)
9 Middle East and Africa Cancer Ablation Devices by Country
9.1 Middle East and Africa Cancer Ablation Devices Historic Market Size by Country
9.1.1 Middle East and Africa Cancer Ablation Devices Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Cancer Ablation Devices Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Cancer Ablation Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Cancer Ablation Devices Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Cancer Ablation Devices Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Cancer Ablation Devices Business
10.1 Alfresa Pharma Corp.
10.1.1 Alfresa Pharma Corp. Corporation Information
10.1.2 Alfresa Pharma Corp. Introduction and Business Overview
10.1.3 Alfresa Pharma Corp. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Alfresa Pharma Corp. Cancer Ablation Devices Products Offered
10.1.5 Alfresa Pharma Corp. Recent Development
10.2 AngioDynamics, Inc.
10.2.1 AngioDynamics, Inc. Corporation Information
10.2.2 AngioDynamics, Inc. Introduction and Business Overview
10.2.3 AngioDynamics, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Alfresa Pharma Corp. Cancer Ablation Devices Products Offered
10.2.5 AngioDynamics, Inc. Recent Development
10.3 BTG plc (Galil Medical Ltd./Perseon Medical)
10.3.1 BTG plc (Galil Medical Ltd./Perseon Medical) Corporation Information
10.3.2 BTG plc (Galil Medical Ltd./Perseon Medical) Introduction and Business Overview
10.3.3 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.3.4 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Products Offered
10.3.5 BTG plc (Galil Medical Ltd./Perseon Medical) Recent Development
10.4 Biomedical S.r.l.
10.4.1 Biomedical S.r.l. Corporation Information
10.4.2 Biomedical S.r.l. Introduction and Business Overview
10.4.3 Biomedical S.r.l. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Biomedical S.r.l. Cancer Ablation Devices Products Offered
10.4.5 Biomedical S.r.l. Recent Development
10.5 Boston Scientific Corporation
10.5.1 Boston Scientific Corporation Corporation Information
10.5.2 Boston Scientific Corporation Introduction and Business Overview
10.5.3 Boston Scientific Corporation Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Boston Scientific Corporation Cancer Ablation Devices Products Offered
10.5.5 Boston Scientific Corporation Recent Development
10.6 CSA Medical, Inc.
10.6.1 CSA Medical, Inc. Corporation Information
10.6.2 CSA Medical, Inc. Introduction and Business Overview
10.6.3 CSA Medical, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.6.4 CSA Medical, Inc. Cancer Ablation Devices Products Offered
10.6.5 CSA Medical, Inc. Recent Development
10.7 Chongqing Haifu Medical Technology Co., Ltd
10.7.1 Chongqing Haifu Medical Technology Co., Ltd Corporation Information
10.7.2 Chongqing Haifu Medical Technology Co., Ltd Introduction and Business Overview
10.7.3 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Products Offered
10.7.5 Chongqing Haifu Medical Technology Co., Ltd Recent Development
10.8 ECO Medical
10.8.1 ECO Medical Corporation Information
10.8.2 ECO Medical Introduction and Business Overview
10.8.3 ECO Medical Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.8.4 ECO Medical Cancer Ablation Devices Products Offered
10.8.5 ECO Medical Recent Development
10.9 EDAP TMS S.A.
10.9.1 EDAP TMS S.A. Corporation Information
10.9.2 EDAP TMS S.A. Introduction and Business Overview
10.9.3 EDAP TMS S.A. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.9.4 EDAP TMS S.A. Cancer Ablation Devices Products Offered
10.9.5 EDAP TMS S.A. Recent Development
10.10 HS Hospital Service S.p.A.
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Cancer Ablation Devices Product Category, Application and Specification
10.10.3 HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 HS Hospital Service S.p.A. Recent Development
10.11 IceCure Medical, Inc.
10.11.1 IceCure Medical, Inc. Corporation Information
10.11.2 IceCure Medical, Inc. Introduction and Business Overview
10.11.3 IceCure Medical, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.11.4 IceCure Medical, Inc. Cancer Ablation Devices Products Offered
10.11.5 IceCure Medical, Inc. Recent Development
10.12 Johnson & Johnson (Ethicon, Inc.)
10.12.1 Johnson & Johnson (Ethicon, Inc.) Corporation Information
10.12.2 Johnson & Johnson (Ethicon, Inc.) Introduction and Business Overview
10.12.3 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Products Offered
10.12.5 Johnson & Johnson (Ethicon, Inc.) Recent Development
10.13 Kang-Yu Medical Co., Ltd.
10.13.1 Kang-Yu Medical Co., Ltd. Corporation Information
10.13.2 Kang-Yu Medical Co., Ltd. Introduction and Business Overview
10.13.3 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Products Offered
10.13.5 Kang-Yu Medical Co., Ltd. Recent Development
10.14 MedLink Technologies LLC
10.14.1 MedLink Technologies LLC Corporation Information
10.14.2 MedLink Technologies LLC Introduction and Business Overview
10.14.3 MedLink Technologies LLC Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.14.4 MedLink Technologies LLC Cancer Ablation Devices Products Offered
10.14.5 MedLink Technologies LLC Recent Development
10.15 MedWaves, Inc.
10.15.1 MedWaves, Inc. Corporation Information
10.15.2 MedWaves, Inc. Introduction and Business Overview
10.15.3 MedWaves, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
10.15.4 MedWaves, Inc. Cancer Ablation Devices Products Offered
10.15.5 MedWaves, Inc. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cancer Ablation Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cancer Ablation Devices Industrial Chain Analysis
11.4 Cancer Ablation Devices Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cancer Ablation Devices Distributors
12.3 Cancer Ablation Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Cancer Ablation Devices Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of Cryoablation
Table 2. Major Company of High-Intensity Focused Ultrasound (HIFU)
Table 3. Major Company of Laser Interstitial Thermal Therapy (LiTT)
Table 4. Major Company of Microwave Ablation (MWA)
Table 5. Major Company of Radiofrequency Ablation (RFA)
Table 6. Major Company of Irreversible Electroporation (Ire)
Table 7. Major Company of Non-Thermal Ablation
Table 8. Global Cancer Ablation Devices Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 9. Global Cancer Ablation Devices Sales by Type (2016-2021) & (K Units)
Table 10. Global Cancer Ablation Devices Sales Market Share in Volume by Type (2016-2021)
Table 11. Global Cancer Ablation Devices Sales by Type (2016-2021) & (US& Million)
Table 12. Global Cancer Ablation Devices Market Share in Value by Type (2016-2021)
Table 13. Global Cancer Ablation Devices Price by Type (2016-2021) & (US$/Unit)
Table 14. Global Cancer Ablation Devices Sales by Type (2022-2027) & (K Units)
Table 15. Global Cancer Ablation Devices Sales Market Share in Volume by Type (2022-2027)
Table 16. Global Cancer Ablation Devices Sales by Type (2022-2027) & (US$ Million)
Table 17. Global Cancer Ablation Devices Sales Market Share in Value by Type (2022-2027)
Table 18. Global Cancer Ablation Devices Price by Type (2022-2027) & (US$/Unit)
Table 19. North America Cancer Ablation Devices Sales by Type (2016-2021) & (K Units)
Table 20. North America Cancer Ablation Devices Sales by Type (2016-2021) & (US$ Million)
Table 21. Europe Cancer Ablation Devices Sales (K Units) by Type (2016-2021)
Table 22. Europe Cancer Ablation Devices Sales by Type (2016-2021) & (US$ Million)
Table 23. Asia-Pacific Cancer Ablation Devices Sales (K Units) by Type (2016-2021)
Table 24. Asia-Pacific Cancer Ablation Devices Sales by Type (2016-2021) & (US$ Million)
Table 25. Latin America Cancer Ablation Devices Sales (K Units) by Type (2016-2021)
Table 26. Latin America Cancer Ablation Devices Sales by Type (2016-2021) & (US$ Million)
Table 27. Middle East and Africa Cancer Ablation Devices Sales (K Units) by Type (2016-2021)
Table 28. Middle East and Africa Cancer Ablation Devices Sales by Type (2016-2021) & (US$ Million)
Table 29. Global Cancer Ablation Devices Sales by Company (2016-2021) & (K Units)
Table 30. Global Cancer Ablation Devices Sales Share by Company (2016-2021)
Table 31. Global Cancer Ablation Devices Revenue by Company (2016-2021) & (US$ Million)
Table 32. Global Cancer Ablation Devices Revenue Share by Company (2016-2021)
Table 33. Global Market Cancer Ablation Devices Price by Company (2016-2021) & (US$/Unit)
Table 34. Global Cancer Ablation Devices Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Cancer Ablation Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Ablation Devices as of 2020
Table 37. Date of Key Manufacturers Enter into Cancer Ablation Devices Market
Table 38. Key Manufacturers Cancer Ablation Devices Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Cancer Ablation Devices Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 41. Global Cancer Ablation Devices Sales by Region (2016-2021) & (K Units)
Table 42. Global Cancer Ablation Devices Sales Market Share in Volume by Region (2016-2021)
Table 43. Global Cancer Ablation Devices Sales by Region (2016-2021) & (US$ Million)
Table 44. Global Cancer Ablation Devices Sales Market Share in Value by Region (2016-2021)
Table 45. Global Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 46. Global Cancer Ablation Devices Sales by Region (2022-2027) & (K Units)
Table 47. Global Cancer Ablation Devices Sales Market Share in Volume by Region (2022-2027)
Table 48. Global Cancer Ablation Devices Sales by Region (2022-2027) & (US$ Million)
Table 49. Global Cancer Ablation Devices Sales Market Share in Value by Region (2022-2027)
Table 50. Global Cancer Ablation Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2022-2027)
Table 51. Global Cancer Ablation Devices Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 52. Global Cancer Ablation Devices Sales by Application (2016-2021) & (K Units)
Table 53. Global Cancer Ablation Devices Sales Market Share in Volume by Application (2016-2021)
Table 54. Global Cancer Ablation Devices Sales by Application (2016-2021) & (US$ Million)
Table 55. Global Cancer Ablation Devices Sales Market Share in Value by Application (2016-2021)
Table 56. Global Cancer Ablation Devices Price by Application (2016-2021) & (US$/Unit)
Table 57. Global Cancer Ablation Devices Sales by Application (2022-2027) & (K Units)
Table 58. Global Cancer Ablation Devices Sales Market Share in Volume by Application (2022-2027)
Table 59. Global Cancer Ablation Devices Sales by Application (2022-2027) & (US$ Million)
Table 60. Global Cancer Ablation Devices Sales Market Share in Value by Application (2022-2027)
Table 61. Global Cancer Ablation Devices Price by Application (2022-2027) & (US$/Unit)
Table 62. North America Cancer Ablation Devices Sales by Application (2016-2021) (K Units)
Table 63. North America Cancer Ablation Devices Sales by Application (2016-2021) & (US$ Million)
Table 64. North America Cancer Ablation Devices Sales Market Share in Value by Application in 2020
Table 65. Europe Cancer Ablation Devices Sales by Application (2016-2021) (K Units)
Table 66. Europe Cancer Ablation Devices Sales by Application (2016-2021) & (US$ Million)
Table 67. Europe Cancer Ablation Devices Sales Market Share in Value by Application in 2020
Table 68. Asia-Pacific Cancer Ablation Devices Sales by Application (2016-2021) (K Units)
Table 69. Asia-Pacific Cancer Ablation Devices Sales by Application (2016-2021) & (US$ Million)
Table 70. Asia-Pacific Cancer Ablation Devices Sales Market Share in Value by Application in 2020
Table 71. Latin America Cancer Ablation Devices Sales by Application (2016-2021) (K Units)
Table 72. Latin America Cancer Ablation Devices Sales by Application (2016-2021) & (US$ Million)
Table 73. Latin America Cancer Ablation Devices Sales Market Share in Value by Application in 2020
Table 74. Middle East and Africa Cancer Ablation Devices Sales by Application (2016-2021) (K Units)
Table 75. Middle East and Africa Cancer Ablation Devices Sales by Application (2016-2021) & (US$ Million)
Table 76. Middle East and Africa Cancer Ablation Devices Sales Market Share in Value by Application in 2020
Table 77. North America Cancer Ablation Devices Sales by Country (2016-2021) & (K Units)
Table 78. North America Cancer Ablation Devices Sales Market Share in Volume by Country (2016-2021)
Table 79. North America Cancer Ablation Devices Sales by Country (2016-2021) & (US$ Million)
Table 80. North America Cancer Ablation Devices Sales Market Share in Value by Country (2016-2021)
Table 81. North America Cancer Ablation Devices Sales by Country (2022-2027) & (K Units)
Table 82. North America Cancer Ablation Devices Sales Market Share in Volume by Country (2022-2027)
Table 83. North America Cancer Ablation Devices Sales by Country (2022-2027) & (US$ Million)
Table 84. North America Cancer Ablation Devices Sales Market Share in Value by Country (2022-2027)
Table 85. Europe Cancer Ablation Devices Sales by Country (2016-2021) & (K Units)
Table 86. Europe Cancer Ablation Devices Sales Market Share in Volume by Country (2016-2021)
Table 87. Europe Cancer Ablation Devices Sales by Country (2016-2021) & (US$ Million)
Table 88. Europe Cancer Ablation Devices Sales Market Share in Value by Country (2016-2021)
Table 89. Europe Cancer Ablation Devices Sales by Country (2022-2027) & (K Units)
Table 90. Europe Cancer Ablation Devices Sales Market Share in Volume by Country (2022-2027)
Table 91. Europe Cancer Ablation Devices Sales by Country (2022-2027) & (US$ Million)
Table 92. Europe Cancer Ablation Devices Sales Market Share in Value by Country (2022-2027)
Table 93. Asia-Pacific Cancer Ablation Devices Sales by Region (2016-2021) & (K Units)
Table 94. Asia-Pacific Cancer Ablation Devices Sales Market Share in Volume by Region (2016-2021)
Table 95. Asia-Pacific Cancer Ablation Devices Sales by Region (2016-2021) & (US$ Million)
Table 96. Asia-Pacific Cancer Ablation Devices Sales Market Share in Value by Region (2016-2021)
Table 97. Asia-Pacific Cancer Ablation Devices Sales by Region (2022-2027) & (K Units)
Table 98. Asia-Pacific Cancer Ablation Devices Sales Market Share in Volume by Region (2022-2027)
Table 99. Asia-Pacific Cancer Ablation Devices Sales by Region (2022-2027) & (US$ Million)
Table 100. Asia-Pacific Cancer Ablation Devices Sales Market Share in Value by Region (2022-2027)
Table 101. Latin America Cancer Ablation Devices Sales by Country (2016-2021) & (K Units)
Table 102. Latin America Cancer Ablation Devices Sales Market Share in Volume by Country (2016-2021)
Table 103. Latin America Cancer Ablation Devices Sales by Country (2016-2021) & (US$ Million)
Table 104. Latin America Cancer Ablation Devices Sales Market Share in Value by Country (2016-2021)
Table 105. Latin America Cancer Ablation Devices Sales by Country (2022-2027) & (K Units)
Table 106. Latin America Cancer Ablation Devices Sales Market Share in Volume by Country (2022-2027)
Table 107. Latin America Cancer Ablation Devices Sales by Country (2022-2027) & (US$ Million)
Table 108. Latin America Cancer Ablation Devices Sales Market Share in Value by Country (2022-2027)
Table 109. Middle East and Africa Cancer Ablation Devices Sales by Country (2016-2021) & (K Units)
Table 110. Middle East and Africa Cancer Ablation Devices Sales Market Share in Volume by Country (2016-2021)
Table 111. Middle East and Africa Cancer Ablation Devices Sales by Country (2016-2021) & (US$ Million)
Table 112. Middle East and Africa Cancer Ablation Devices Sales Market Share in Value by Country (2016-2021)
Table 113. Middle East and Africa Cancer Ablation Devices Sales by Country (2022-2027) & (K Units)
Table 114. Middle East and Africa Cancer Ablation Devices Sales Market Share in Volume by Country (2022-2027)
Table 115. Middle East and Africa Cancer Ablation Devices Sales by Country (2022-2027) & (US$ Million)
Table 116. Middle East and Africa Cancer Ablation Devices Sales Market Share in Value by Country (2022-2027)
Table 117. Alfresa Pharma Corp. Corporation Information
Table 118. Alfresa Pharma Corp. Introduction and Business Overview
Table 119. Alfresa Pharma Corp. Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Alfresa Pharma Corp. Cancer Ablation Devices Product
Table 121. Alfresa Pharma Corp. Recent Development
Table 122. AngioDynamics, Inc. Corporation Information
Table 123. AngioDynamics, Inc. Introduction and Business Overview
Table 124. AngioDynamics, Inc. Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. AngioDynamics, Inc. Cancer Ablation Devices Product
Table 126. AngioDynamics, Inc. Recent Development
Table 127. BTG plc (Galil Medical Ltd./Perseon Medical) Corporation Information
Table 128. BTG plc (Galil Medical Ltd./Perseon Medical) Introduction and Business Overview
Table 129. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Product
Table 131. BTG plc (Galil Medical Ltd./Perseon Medical) Recent Development
Table 132. Biomedical S.r.l. Corporation Information
Table 133. Biomedical S.r.l. Introduction and Business Overview
Table 134. Biomedical S.r.l. Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Biomedical S.r.l. Cancer Ablation Devices Product
Table 136. Biomedical S.r.l. Recent Development
Table 137. Boston Scientific Corporation Corporation Information
Table 138. Boston Scientific Corporation Introduction and Business Overview
Table 139. Boston Scientific Corporation Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Boston Scientific Corporation Cancer Ablation Devices Product
Table 141. Boston Scientific Corporation Recent Development
Table 142. CSA Medical, Inc. Corporation Information
Table 143. CSA Medical, Inc. Introduction and Business Overview
Table 144. CSA Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. CSA Medical, Inc. Cancer Ablation Devices Product
Table 146. CSA Medical, Inc. Recent Development
Table 147. Chongqing Haifu Medical Technology Co., Ltd Corporation Information
Table 148. Chongqing Haifu Medical Technology Co., Ltd Introduction and Business Overview
Table 149. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Product
Table 151. Chongqing Haifu Medical Technology Co., Ltd Recent Development
Table 152. ECO Medical Corporation Information
Table 153. ECO Medical Introduction and Business Overview
Table 154. ECO Medical Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. ECO Medical Cancer Ablation Devices Product
Table 156. ECO Medical Recent Development
Table 157. EDAP TMS S.A. Corporation Information
Table 158. EDAP TMS S.A. Introduction and Business Overview
Table 159. EDAP TMS S.A. Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 160. EDAP TMS S.A. Cancer Ablation Devices Product
Table 161. EDAP TMS S.A. Recent Development
Table 162. HS Hospital Service S.p.A. Corporation Information
Table 163. HS Hospital Service S.p.A. Introduction and Business Overview
Table 164. HS Hospital Service S.p.A. Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 165. HS Hospital Service S.p.A. Cancer Ablation Devices Product
Table 166. HS Hospital Service S.p.A. Recent Development
Table 167. IceCure Medical, Inc. Corporation Information
Table 168. IceCure Medical, Inc. Introduction and Business Overview
Table 169. IceCure Medical, Inc. Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 170. IceCure Medical, Inc. Cancer Ablation Devices Product
Table 171. IceCure Medical, Inc. Recent Development
Table 172. Johnson & Johnson (Ethicon, Inc.) Corporation Information
Table 173. Johnson & Johnson (Ethicon, Inc.) Introduction and Business Overview
Table 174. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 175. Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Product
Table 176. Johnson & Johnson (Ethicon, Inc.) Recent Development
Table 177. Kang-Yu Medical Co., Ltd. Corporation Information
Table 178. Kang-Yu Medical Co., Ltd. Introduction and Business Overview
Table 179. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 180. Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Product
Table 181. Kang-Yu Medical Co., Ltd. Recent Development
Table 182. MedLink Technologies LLC Corporation Information
Table 183. MedLink Technologies LLC Introduction and Business Overview
Table 184. MedLink Technologies LLC Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 185. MedLink Technologies LLC Cancer Ablation Devices Product
Table 186. MedLink Technologies LLC Recent Development
Table 187. MedWaves, Inc. Corporation Information
Table 188. MedWaves, Inc. Introduction and Business Overview
Table 189. MedWaves, Inc. Cancer Ablation Devices Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 190. MedWaves, Inc. Cancer Ablation Devices Product
Table 191. MedWaves, Inc. Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Cancer Ablation Devices Market Trends
Table 195. Cancer Ablation Devices Market Drivers
Table 196. Cancer Ablation Devices Market Challenges
Table 197. Cancer Ablation Devices Market Restraints
Table 198. Cancer Ablation Devices Distributors List
Table 199. Cancer Ablation Devices Downstream Customers
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Ablation Devices Product Picture
Figure 2. Global Cancer Ablation Devices Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Cancer Ablation Devices Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Cancer Ablation Devices Sales Status and Outlook (2016-2027) & (K Units)
Figure 5. Product Picture of Cryoablation
Figure 6. Global Cryoablation Sales YoY Growth (2016-2021) & (K Units)
Figure 7. Product Picture of High-Intensity Focused Ultrasound (HIFU)
Figure 8. Global High-Intensity Focused Ultrasound (HIFU) Sales YoY Growth (2016-2021) & (K Units)
Figure 9. Product Picture of Laser Interstitial Thermal Therapy (LiTT)
Figure 10. Global Laser Interstitial Thermal Therapy (LiTT) Sales YoY Growth (2016-2021) & (K Units)
Figure 11. Product Picture of Microwave Ablation (MWA)
Figure 12. Global Microwave Ablation (MWA) Sales YoY Growth (2016-2021) & (K Units)
Figure 13. Product Picture of Radiofrequency Ablation (RFA)
Figure 14. Global Radiofrequency Ablation (RFA) Sales YoY Growth (2016-2021) & (K Units)
Figure 15. Product Picture of Irreversible Electroporation (Ire)
Figure 16. Global Irreversible Electroporation (Ire) Sales YoY Growth (2016-2021) & (K Units)
Figure 17. Product Picture of Non-Thermal Ablation
Figure 18. Global Non-Thermal Ablation Sales YoY Growth (2016-2021) & (K Units)
Figure 19. Global Cancer Ablation Devices Sales by Type (2016-2027) & (US$ Million)
Figure 20. Global Cancer Ablation Devices Sales Market Share in Volume by Type (2016-2021)
Figure 21. Global Cancer Ablation Devices Sales Market Share in Value by Type (2016-2021)
Figure 22. Global Cancer Ablation Devices Sales Market Share in Volume by Type (2022-2027)
Figure 23. Global Cancer Ablation Devices Sales Market Share in Value by Type (2022-2027)
Figure 24. North America Cancer Ablation Devices Sales Market Share in Volume by Type in 2020
Figure 25. North America Cancer Ablation Devices Sales Market Share in Value by Type in 2020
Figure 26. Europe Cancer Ablation Devices Sales Market Share in Volume by Type in 2020
Figure 27. Europe Cancer Ablation Devices Sales Market Share in Value by Type in 2020
Figure 28. Asia-Pacific Cancer Ablation Devices Sales Market Share in Volume by Type in 2020
Figure 29. Asia-Pacific Cancer Ablation Devices Sales Market Share in Value by Type in 2020
Figure 30. Latin America Cancer Ablation Devices Sales Market Share in Volume by Type in 2020
Figure 31. Latin America Cancer Ablation Devices Sales Market Share in Value by Type in 2020
Figure 32. Middle East and Africa Cancer Ablation Devices Sales Market Share in Volume by Type in 2020
Figure 33. Middle East and Africa Cancer Ablation Devices Sales Market Share in Value by Type in 2020
Figure 34. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Ablation Devices Sales in 2020
Figure 35. The 5 and 10 Largest Manufacturers in the World: Market Share by Cancer Ablation Devices Revenue in 2020
Figure 36. Cancer Ablation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 37. Product Picture of Brain Cancer
Figure 38. Global Brain Cancer Sales YoY Growth (2016-2027) & (K Units)
Figure 39. Product Picture of Brown
Figure 40. Global Brown Sales YoY Growth (2016-2027) & (K Units)
Figure 41. Product Picture of Colorectal Cancer
Figure 42. Global Colorectal Cancer Sales YoY Growth (2016-2027) & (K Units)
Figure 43. Product Picture of Kidney Cancer
Figure 44. Global Kidney Cancer Sales YoY Growth (2016-2027) & (K Units)
Figure 45. Product Picture of Liver Cancer
Figure 46. Global Liver Cancer Sales YoY Growth (2016-2027) & (K Units)
Figure 47. Product Picture of Lung Cancer
Figure 48. Global Lung Cancer Sales YoY Growth (2016-2027) & (K Units)
Figure 49. Product Picture of Pancreatic Cancer
Figure 50. Global Pancreatic Cancer Sales YoY Growth (2016-2027) & (K Units)
Figure 51. Product Picture of Prostate Cancer
Figure 52. Global Prostate Cancer Sales YoY Growth (2016-2027) & (K Units)
Figure 53. Global Cancer Ablation Devices Sales by Application (2016-2027) & (US$ Million)
Figure 54. Global Cancer Ablation Devices Sales Market Share in Volume by Application (2016-2021)
Figure 55. Global Cancer Ablation Devices Sales Market Share in Value by Application (2016-2021)
Figure 56. Global Cancer Ablation Devices Sales Market Share in Volume by Application (2022-2027)
Figure 57. North America Cancer Ablation Devices Sales Market Share in Volume by Application in 2020
Figure 58. Latin America Cancer Ablation Devices Sales Market Share in Value by Application in 2020
Figure 59. Middle East and Africa Cancer Ablation Devices Sales Market Share in Value by Application in 2020
Figure 60. Key Raw Materials Price
Figure 61. Cancer Ablation Devices Manufacturing Cost Structure
Figure 62. Cancer Ablation Devices Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Keyplayers in Global Cancer Ablation Devices Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
Alfresa Pharma Corp.AngioDynamics, Inc.
BTG plc (Galil Medical Ltd./Perseon Medical)
Biomedical S.r.l.
Boston Scientific Corporation
CSA Medical, Inc.
Chongqing Haifu Medical Technology Co., Ltd
ECO Medical
EDAP TMS S.A.
HS Hospital Service S.p.A.
IceCure Medical, Inc.
Johnson & Johnson (Ethicon, Inc.)
Kang-Yu Medical Co., Ltd.
MedLink Technologies LLC
MedWaves, Inc.